In the case of our ME/CFS study cohort the fatigue severity scale correlated with GDF15 levels, these findings lend further support for a role for GDF15 as a marker of symptom severity in ME/CFS. This evidence concerns the gene GDF15 and myalgic encephalomeyelitis/chronic fatigue syndrome.